Leading Companies Fueling Innovation and Growth in the Automation in Biopharma Industry Market

The automation sector within the biopharma industry is on track for remarkable expansion, driven by technological innovations and shifting market demands. As pharmaceutical processes become increasingly complex, automating these stages offers significant benefits in efficiency and quality assurance. This overview highlights the current market size, key players, emerging trends, and segmentation details shaping the future of automation in biopharma.

Projected Market Size and Growth Forecast in Automation in Biopharma Industry
The automation in biopharma industry market is expected to experience substantial growth in the coming years, reaching a valuation of $2.92 billion by 2029. This expansion reflects a compound annual growth rate (CAGR) of 7.4%. The accelerating growth is fueled by factors such as improved data integrity and documentation practices, the rise of personalized medicine, and the increasing adoption of modular and flexible bioprocessing facilities. Additionally, ongoing evolution in automation platforms, growing demand for biosimilars, and integration of smart sensors and the Internet of Things (IoT) are playing crucial roles. Key market trends include advancements in robotics and automation technologies, progress in single-use technologies, the growing role of artificial intelligence in bioprocessing, development in process analytical technologies (PAT), collaborations between biopharma firms and tech companies, and a heightened focus on sustainability within biopharma automation.

Download a free sample of the automation in biopharma industry market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

Leading Players Influencing the Automation in Biopharma Industry Market
Several major corporations dominate the automation in biopharma industry market landscape. These include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton dic*kinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, and BioTek Instruments Inc.

A notable development occurred in April 2022 when Bruker Corporation, a US-based company specializing in scientific instruments for molecular and materials research, acquired Optimal Industrial Automation Limited, a UK-based provider of pharmaceutical and biopharmaceutical automation solutions. This acquisition enhances Bruker's capabilities as a software and solutions provider for pharma companies focused on small molecules, biologics, and new drug modalities. Optimal Industrial Automation Limited specializes in process analytical technology (PAT), manufacturing automation, quality assurance software, and system integration.

View the full automation in biopharma industry market report:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Technological Innovations Steering the Future of Automation in Biopharma Industry
Technological progress remains a vital driver for growth in the automation in biopharma industry market. Leading companies are investing heavily in developing cutting-edge product technologies to secure a competitive edge. For example, in September 2022, PerkinElmer Inc. introduced the Cellaca PLX Image Cytometry System, an advanced automated platform designed to simplify cell and gene therapy research and manufacturing workflows. This system enables precise evaluation of critical quality attributes of cell samples-such as identity, quantity, and quality-through an integrated automated process. The platform combines hardware, software, validated consumables, and data reporting tools, streamlining calibration and user training for researchers.

Market Segmentation of Automation in Biopharma Industry by Technology, Components, and Applications
The automation in biopharma industry market is segmented into various categories for detailed analysis. By technology, the market divides into automation technology and digitization technology. Automation technology further breaks down into process automation, laboratory automation, robotics and artificial intelligence, control systems, and programmable logic controllers (PLCs). Digitization technology includes data analytics and visualization, electronic lab notebooks (ELN), cloud computing, Internet of Things (IoT) in pharma, and digital twin technology.

Component-wise segmentation covers automation hardware, automation software, services during the project phase, and services during the operation phase. From an application perspective, the market spans across clinical phase, drug discovery phase, and production phase, reflecting the diverse use cases of automation throughout the biopharma lifecycle.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.